Oncology Biosimilars Market Growth, Demand and Production Forecast 2035
According to Payal Rabde, who specializes in the development, manufacturing, and commercialization of biologic medicines, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the oncology biosimilars market. The global oncology biosimilars market size was estimated at USD 6.7 billion in 2025 and is predicted to increase from USD 9.41 billion in 2026 to approximately USD 36.23 billion by 2034, expanding at a CAGR of 18.47% from 2026 to 2035.
Last Updated : 05 October 2026
Category: Therapeutic Area
Insight Code: 6020
Format: PDF / PPT / Excel